Product Focus: Regranex® (becaplermin, rh-PDGF)

October 3, 2022

REGRANEX® (BECAPLERMIN) GEL IS BACK IN STOCK FROM SMITH & NEPHEW, INC Description: REGRANEX® gel is the only FDA-approved PDGF for the treatment of diabetic neuropathic ulcers, formulated to act as a first-line treatment following effective ulcer care. REGRANEX® gel features endogenous platelet-derived growth factor (PDGF) therapy, shown to initiate the healing process by attracting…